ALYSSA FRANCISCO: Open Payments
NPI 1841835634 · COLUMBUS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,005 in 40 payments from 19 companies in 2025. Trend: 2023 $727 · 2024 $1,194 · 2025 $1,005
Food & beverage: $1,005
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 8 | $169 |
| Boston Scientific Corporation | 4 | $131 |
| TOLMAR, INC. | 3 | $94 |
| Merck Sharp & Dohme LLC | 3 | $78 |
| 180 Medical, Inc. | 3 | $64 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $51 |
| BIOPROTECT MEDICAL, INC. | 2 | $47 |
| ConvaTec Inc. | 1 | $45 |
| Endo USA, Inc. | 2 | $41 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $38 |
Products named: GEMTESA, JATENZO, GENTLECATH GLIDE, LYNPARZA, ORGOVYX, LithoVue, Nubeqa, BIOPROTECT BALLOON IMPLANT SYSTEM.
Industry payments across GA — which companies pay providers there.
